Cargando…
The efficacy of mesenchymal stromal cell-derived therapies for acute respiratory distress syndrome—a meta-analysis of preclinical trials
BACKGROUND: The investigation of mesenchymal stromal cell (MSC)-conditioned medium or extracellular vesicles (exosomes or microvesicles) as a remedy for acute lung injury (ALI) or acute respiratory distress syndrome (ARDS) has become a fast-growing field in recent years. Our purpose was to conduct a...
Autores principales: | Wang, Fengyun, Fang, Bin, Qiang, Xinhua, Shao, Jingsong, Zhou, Lixin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677103/ https://www.ncbi.nlm.nih.gov/pubmed/33218340 http://dx.doi.org/10.1186/s12931-020-01574-y |
Ejemplares similares
-
Mesenchymal Stromal Cells Attenuate Infection-Induced Acute Respiratory Distress Syndrome in Animal Experiments: A Meta-Analysis
por: Fengyun, Wang, et al.
Publicado: (2020) -
The fluid management and hemodynamic characteristics of PiCCO employed on young children with severe hand, foot, and mouth disease—a retrospective study
por: Wang, Fengyun, et al.
Publicado: (2021) -
Advances in mesenchymal stromal cell therapy for acute lung injury/acute respiratory distress syndrome
por: Liu, Chang, et al.
Publicado: (2022) -
Enhancing the Efficacy of Mesenchymal Stromal Cells in COVID-19–related Acute Respiratory Distress Syndrome
por: Zhang, Haibo, et al.
Publicado: (2023) -
Mesenchymal Stem/Stromal Cells: SAFETY OF CORD TISSUE DERIVED MESENCHYMAL STROMAL CELLS IN COVID-19 RELATED ACUTE RESPIRATORY DISTRESS SYNDROME
por: Shaz, B., et al.
Publicado: (2022)